We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.37B
Cap. Flow %
30.06%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3 quarters
Top 10 Avg Time Held Equity + Options
0.9 quarters
Top 20 Avg Time Held Equity + Options
0.9 quarters
Avg Time Held Equity only
1.2 quarters
Top 10 Avg Time Held Equity only
0.9 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$645M
2
NUAN
Nuance Communications, Inc.
NUAN
+$539M
3
MXIM
Maxim Integrated Products
MXIM
+$525M
4
VER
VEREIT, Inc.
VER
+$520M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$491M

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$475M
2
RP
RealPage, Inc.
RP
+$281M
3
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$209M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$170M
5
CLGX
Corelogic, Inc.
CLGX
+$160M

Sector Composition

Rank Sector Weight
1 Technology 26.69%
2 Healthcare 19.01%
3 Financials 14.31%
4 Real Estate 10.94%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OSI.U icon
401
DELISTED
Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
OSI.U
$2.48M 0.02%
+250,000
New +$2.49M
2021 Q2
0 quarters
TWOA
402
DELISTED
two
TWOA
$2.47M 0.02%
+250,979
New +$2.49M
2021 Q2
0 quarters
PEAR
403
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$2.47M 0.02%
249,991
– –
2021 Q1
1 quarter
LUXA
404
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$2.47M 0.02%
249,991
– –
2021 Q1
1 quarter
GSQD
405
DELISTED
G Squared Ascend I Inc.
GSQD
$2.46M 0.02%
+249,793
New +$2.46M
2021 Q2
0 quarters
GRNA
406
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$2.46M 0.02%
251,162
-348,424
-58% -$3.4M
2021 Q1
1 quarter
ENJY
407
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$2.46M 0.02%
248,903
-251,079
-50% -$2.48M
2021 Q1
1 quarter
ALTU
408
DELISTED
Altitude Acquisition Corp
ALTU
$2.46M 0.02%
250,979
-100,391
-29% -$990K
2021 Q1
1 quarter
OCA
409
DELISTED
Omnichannel Acquisition Corp.
OCA
$2.46M 0.02%
249,991
– –
2021 Q1
1 quarter
TSIB icon
410
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$2.45M 0.02%
+248,680
New +$2.46M
2021 Q2
0 quarters
FRW
411
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
$2.45M 0.02%
+250,164
New +$2.46M
2021 Q2
0 quarters
IGAC icon
412
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$2.44M 0.02%
250,979
– –
2020 Q4
2 quarters
COLD icon
413
Americold
COLD
$3.99B
$2.44M 0.02%
64,540
+34,040
+112% +$1.32M
2018 Q3
11 quarters
PV
414
DELISTED
Primavera Capital Acquisition Corporation
PV
$2.44M 0.02%
249,991
– –
2021 Q1
1 quarter
HGAS icon
415
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$2.44M 0.02%
+249,497
New +$2.44M
2021 Q2
0 quarters
COLI
416
DELISTED
Colicity Inc. Class A Common Stock
COLI
$2.44M 0.02%
+250,000
New +$2.45M
2021 Q2
0 quarters
SPGS
417
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
$2.44M 0.02%
+250,000
New +$2.46M
2021 Q2
0 quarters
RUM icon
418
RUM Group Inc
RUM
$3.33B
$2.44M 0.02%
+250,196
New +$2.44M
2021 Q2
0 quarters
FRON
419
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$2.44M 0.02%
+250,164
New +$2.45M
2021 Q2
0 quarters
RXRA
420
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
$2.44M 0.02%
+250,979
New +$2.46M
2021 Q2
0 quarters
AMPI
421
DELISTED
Advanced Merger Partners Inc
AMPI
$2.44M 0.02%
+250,164
New +$2.45M
2021 Q2
0 quarters
HLAH
422
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$2.44M 0.02%
249,991
– –
2021 Q1
1 quarter
EPWR
423
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$2.44M 0.02%
249,200
– –
2021 Q1
1 quarter
LGAC
424
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$2.44M 0.02%
+249,003
New +$2.45M
2021 Q2
0 quarters
SLAM icon
425
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.43M 0.02%
+249,804
New +$2.44M
2021 Q2
0 quarters
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.